L'Agence européenne du médicament vient d'approuver un traitement destiné aux formes précoces de la maladie d'Alzheimer.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback